Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENTA 16 short-cycle therapy trial in young people with chronic HIV infection
ISRCTN97755073Phase 3Completed
- Sponsor
- Penta Foundation
- Start
- Mar 2011
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of efavirenz in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Penta Foundation. Primary endpoint: Confirmed virological rebound. Started Mar 2011; status: completed.
02
Drugs
efavirenz
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on ISRCTN97755073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN97755073.